SEC Comment Letter for MYRIAD GENETICS INC (MYGN) (CIK 0000899923) (MYGN) — Sep 29, 2008

MYRIAD GENETICS INC (MYGN) (CIK 0000899923)
Date: Sept. 29, 2008 · CIK: 0000899923 · Accession: 0000000000-08-048899

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-26642

Date

September 29, 2008

Author

Jeffrey P. Riedler

Form

UPLOAD

Company

MYRIAD GENETICS INC (MYGN) (CIK 0000899923)

Letter

Mail Stop 6010 September 29, 2008 Richard Marsh Executive Vice President, General Counsel and Secretary Myriad Genetics, Inc. 320 Wakara Way Salt Lake City, Utah 84108 Re: Myriad Genetics, Inc. Preliminary Proxy Statement on Schedule 14A Filed September 18, 2008 File No. 000-26642

Dear Mr. Marsh: We have completed our review of your preliminary proxy statement on Schedule 14A and have no further comments at this time.

Sincerely,
J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

Show Raw Text

Mail Stop 6010                                                                                                   September 29, 2008   Richard Marsh Executive Vice President, General Counsel and Secretary Myriad Genetics, Inc.  320 Wakara Way  Salt Lake City, Utah 84108
Re: Myriad Genetics, Inc.
  Preliminary Proxy Statement on Schedule 14A
Filed September 18, 2008
  File No. 000-26642

Dear Mr. Marsh:
  We have completed our review of  your preliminary proxy statement on
Schedule 14A and have no further comments at this time.

Sincerely,

          J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

cc: Scott A. Samuels, Esq.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
      One Financial Center
Boston, MA 02111

SecProbe.io